1 option
Resistance in hematologic malignancies and cancer / Lucia Messingerova and Albert Breier, editors.
- Format:
- Book
- Series:
- Cancer sensitizing agents for chemotherapy ; Volume 22.
- Cancer Sensitizing Agents for Chemotherapy Series ; Volume 22
- Language:
- English
- Subjects (All):
- Drug resistance in cancer cells.
- Hematological oncology.
- Physical Description:
- 1 online resource (517 pages)
- Edition:
- First edition.
- Place of Publication:
- London, England : Academic Press, [2025]
- Summary:
- This book, part of the 'Cancer Sensitizing Agents for Chemotherapy' series, addresses the challenge of drug resistance in hematologic malignancies and other cancers. It explores the molecular, cellular, and clinical aspects of resistance, aiming to enhance understanding and facilitate the development of new therapeutic strategies. The book includes contributions from experts in the field and covers various sensitizing agents that can be used in combination with chemotherapy to overcome resistance, improve treatment efficacy, and potentially reverse tumor cell resistance. It is intended for scientists and clinicians seeking updated information on novel therapies to improve cancer patient outcomes. Generated by AI.
- Contents:
- Front Cover
- Resistance in Hematologic Malignancies and Cancer
- Copyright
- Cover Image Insert
- Aims and Scope for Series ``Cancer Sensitizing Agents for Chemotherapy´´
- About the Series Editor
- Acknowledgments
- Aims and Scope of Volume
- Volume Editor Biography
- Preface
- Contents
- Contributors
- Chapter 1: Drug classification for the treatment of hematologic malignancies
- Introduction
- Chemotherapeutic drugs
- Alkylating agents
- Antimetabolites
- Natural alkaloids with antitubulin activity
- Cytotoxic antibiotics
- Fixed-dose combination drugs
- Small-molecule anticancer drugs
- Tyrosine kinase inhibitors
- Multikinase inhibitors
- Phosphatidylinositol 3-kinase inhibitors
- Enzyme inhibitors
- Histone deacetylase inhibitors
- Isocitrate dehydrogenase inhibitors
- Enhancer ofzZeste homolog 2 inhibitor
- DNA and RNA methyltransferases inhibitor
- Smoothed receptor antagonists Generated by AI.
- Notes:
- Description based on publisher supplied metadata and other sources.
- Description based on print version record.
- Part of the metadata in this record was created by AI, based on the text of the resource.
- Includes bibliographical references and index.
- ISBN:
- 9780443217913
- 0443217912
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.